Mintai Peter Hwang

Mintai Peter Hwang is a Principal Scientist at Regeneron since January 2020, leading process development for AAV-based gene therapies and Dupixent technology transfer. Previously, Hwang held roles such as Senior Scientist, where studies on REGEN-COV and Inmazeb were conducted, and as a Postdoctoral Associate and Graduate Research Fellow at Cornell University. Hwang's earlier experience includes research positions at the University of Pittsburgh and the Korea Institute of Science and Technology, along with a summer internship at Regeneron Pharmaceuticals. Hwang's educational qualifications include a Ph.D. in Biomedical Engineering from Cornell University and an M.S. in Biomedical Engineering from Columbia University, with a B.S. in Biomedical Engineering from Johns Hopkins University.